Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

The role of topoisomerase II alpha and beta in drug resistance.

Cancer treatment reviews - 1 Apr 1993

Hochhauser D, Harris A L

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cytosol
Share to DNA Topoisomerases, Type II
Share to Down-Regulation
Share to Drug Resistance

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Gene Expression Regulation, Neoplastic

Share to Mutation

Share to Neoplasms

Share to Tumor Cells, Cultured

Source

Identifiers

PMID: 8386983
DOI: 10.1016/0305-7372(93)90034-o

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

The role of topoisomerase II alpha and beta in drug resistance.PMID 8386983Read ↗

Drug resistance mechanisms of topoisomerase I drugs.Semantic proximity Read ↗

Drug resistance associated with altered DNA topoisomerase II.Semantic proximity Read ↗

Clinical resistance to topoisomerase-targeted drugsSemantic proximity Read ↗

DNA topoisomerase II mutations and resistance to anti-tumor drugs.Semantic proximity Read ↗

Mechanisms regulating resistance to inhibitors of topoisomerase IISemantic proximity Read ↗

Topoisomerase IIα, rather than IIβ, is a promising target in development of anti-cancer drugsSemantic proximity Read ↗

Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive ReviewSemantic proximity Read ↗

Cracking the Code: Understanding Cancer’s Defense against Topoisomerase-Active Drugs: A Comprehensive ReviewSemantic proximity Read ↗

Recent developments in DNA topoisomerase II structure and mechanismSemantic proximity Read ↗

Topoisomerase degradation, DSB repair, p53 and IAPs in cancer cell resistance to camptothecin-like topoisomerase I inhibitorsSemantic proximity Read ↗

Type I DNA TopoisomerasesSemantic proximity Read ↗

Studies on Non-synonymous Polymorphisms Altering Human DNA Topoisomerase II-Alpha Interaction with Amsacrine and Mitoxantrone: An In Silico Approach.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.